Tuesday, February 11, 2025 10:44:35 AM
Not so fast, let's not slap an investor of the decade hat on you.
Since you've come here your opinion has fluctuated based upon what day of the week it is. I'm sure you've been trading the stock and that's fine but you've flip-flopped considerably over the years.
Your first week here you were touting approval in 2021 and eventually a 30B market cap, how has that prediction turned out? FWIW from Day 1 I've never pivoted from my opinion, I stated that I hope for cancer patients' sake that the science works but I had zero doubt that LP would dilute investors into oblivion (I always said she's dealing from the bottom of the deck). 2B O/S is definitely in play how many tens of millions do you think will be needed to ramp up to full production if this is ever approved?
Nice to see that you were able to find some entity to give an update on the MHRA application but can we both agree that it shouldn't be this hard for investors to get updates?
and not its prognose for 2021 or 2022 (which looks pretty grim after DCVAX L is approved).
Since DCVAX L revenue could grow as big as 3 billion, x15 would mean a MC of 30 billion in the future and at least 50% of that after or just before approval.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167018973
Since you've come here your opinion has fluctuated based upon what day of the week it is. I'm sure you've been trading the stock and that's fine but you've flip-flopped considerably over the years.
Your first week here you were touting approval in 2021 and eventually a 30B market cap, how has that prediction turned out? FWIW from Day 1 I've never pivoted from my opinion, I stated that I hope for cancer patients' sake that the science works but I had zero doubt that LP would dilute investors into oblivion (I always said she's dealing from the bottom of the deck). 2B O/S is definitely in play how many tens of millions do you think will be needed to ramp up to full production if this is ever approved?
Nice to see that you were able to find some entity to give an update on the MHRA application but can we both agree that it shouldn't be this hard for investors to get updates?
and not its prognose for 2021 or 2022 (which looks pretty grim after DCVAX L is approved).
Since DCVAX L revenue could grow as big as 3 billion, x15 would mean a MC of 30 billion in the future and at least 50% of that after or just before approval.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167018973
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
